Hepatitis E Vaccine Shows Long-Term Efficacy Hepatitis E Vaccine Shows Long-Term Efficacy
While the hepatitis E virus causes tens of thousands of deaths each year, data suggest that a vaccine approved in China has long-term efficacy.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 8, 2024 Category: Allergy & Immunology Tags: Infectious Diseases Source Type: news
Regulatory Education for Industry (REdI) Annual Conference 2024: Biologics Track
The Biologics Track will focus on the developmental and regulatory topics relevant to cellular and gene therapies, tissue-engineered products, blood products, vaccines, and other biological products. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 8, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Therapeutic Vaccine Prevents Pancreatic Cancer's Recurrence in 3-Year Trial
MONDAY, April 8, 2024 -- A pancreatic cancer vaccine has continued to protect a small group of patients from their cancer coming back, three years after receiving the jab, a new study says.Eight patients have not had their pancreatic cancer recur... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 8, 2024 Category: General Medicine Source Type: news
Vaccine-by-Mouth Could Replace Antibiotics in Fighting UTIs
MONDAY, April 8, 2024 -- A new oral vaccine could prove a potential alternative to antibiotics for people with recurring urinary tract infections, a new study says.More than half of patients with recurring UTIs (54%) wound up infection-free for... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 8, 2024 Category: General Medicine Source Type: news
Scientists Develop Vaccine Against Lethal Xylazine, Often Mixed With Street Drugs
MONDAY, April 8, 2024 (HealthDay news) -- A new vaccine might be able to block the toxic effects of the animal tranquilizer xylazine, which is being added to illicit drugs and increasing overdose risk.The vaccine trains the immune system to attack... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 8, 2024 Category: General Medicine Source Type: news
Harnessing children's picture books to socialize children about pain and injury: a qualitative study - Wallwork SB, Nichols S, Jordan A, Noel M, Madden VJ, Lorimer Moseley G.
Pain experiences are common during childhood (e.g., 'everyday' pain, vaccine injections) and are powerful opportunities for children to learn about pain and injury. These experiences likely inform fundamental and life-long beliefs about pain. There is scan... (Source: SafetyLit)
Source: SafetyLit - April 8, 2024 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news
Recurrent UTI Patients Find Long-Term Ally in Oral Vaccine Recurrent UTI Patients Find Long-Term Ally in Oral Vaccine
A vaccine for urinary tract infection is effective for up to 9 years and can resolve cases in which antibiotics have failed.Medscape News UK (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - April 8, 2024 Category: Infectious Diseases Tags: Urology Source Type: news
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in …
Three-year follow-up data of an investigator-initiated Phase 1 trial of the individualized mRNA cancer vaccine candidate autogene cevumeran (BNT122, RO7198457) continue to show polyspecific T cell responses up to three years and delayed tumor recurrence in patients with resected pancreatic ductal…#phase1 #bnt122 #pdac #phase2 #autogene #genentechinc #genentech #rochegroup #inest #bntx (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2024 Category: Consumer Health News Source Type: news
Geneos cancer vaccine shrinks liver tumors in small trial
Nearly a third of patients with advanced liver cancer who received a personalized vaccine developed by Geneos Therapeutics along with an immunotherapy drug in a small, early trial saw their tumors shrink, U.S. researchers reported on Sunday. The result was roughly twice the response typically seen…#geneostherapeutics #sandiego #naturemedicine #merckandco #markyarchoan #merck #keytruda #yarchoan #rna #geneos (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2024 Category: Consumer Health News Source Type: news
Geneos Cancer Vaccine Shrinks Liver Tumors in Small Trial Geneos Cancer Vaccine Shrinks Liver Tumors in Small Trial
Nearly a third of patients with advanced liver cancer who received a personalized vaccine developed by Geneos Therapeutics along with an immunotherapy drug in a small, early...Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 7, 2024 Category: Allergy & Immunology Tags: Hematology-Oncology Source Type: news
Will Human-to-Human Bird Flu (H5N1) Be the Long-Awaited “Disease X?”
Influenza A virus subtype H5N1(“Bird Flu”)[1], which is global, rapidly spreading, and “highly pathogenic,” is now infecting cattle, and (in the United States) at least one human. (Bird flu first emerged in China in 1996 in geese; from a useful potted history). The New York Times asks: “Is Bird…#influenzaa #geese #betteridge #vaccines #aphis #faq #dairyherds #pdf #cdc #delta (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2024 Category: Consumer Health News Source Type: news
Vaccine that can stop UTIs for NINE years - in drug that could prove a saviour for up to 1.7 million Britons
Research has found the treatment can prevent urinary tract infections (UTIs) for up to nine years in more than half of patients. The vaccine is given as a pineapple- flavoured oral spray. (Source: the Mail online | Health)
Source: the Mail online | Health - April 7, 2024 Category: Consumer Health News Source Type: news
Is Bird Flu Coming to People Next? Are We Ready?
Unlike the coronavirus, the H5N1 virus has been studied for years. Vaccines and treatments are available should they ever become necessary. (Source: NYT Health)
Source: NYT Health - April 5, 2024 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: Avian Influenza Vaccination and Immunization Source Type: news
Malawi: Global Deployment of Rapid Diagnostic Tests to Boost Fight Against Cholera
[GAVI] Geneva/New York -- More than 1.2 million cholera rapid diagnostic tests will be shipped to 14 countries in largest-ever global deployment, with the first shipment landing today in Malawi. This first official deployment of tests through Gavi, the Vaccine Alliance, will improve timely detection and monitoring of outbreaks, effectiveness of vaccination campaigns in response to current outbreaks, and targeting of future preventive vaccination efforts. The global cholera rapid diagnostic test procurement programme is a (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 5, 2024 Category: African Health Tags: Aid and Assistance Cameroon Central Africa East Africa Ethiopia Health and Medicine Malawi Sierra Leone Somalia Southern Africa West Africa Zambia Source Type: news
Theralase Secures Patent for Cancer Vaccine
Theralase Technologies (TSE:TLT) has released an update. Theralase Technologies Inc. has been awarded a Canadian patent for an innovative cancer va...#tse #tlt (Source: Reuters: Health)
Source: Reuters: Health - April 5, 2024 Category: Consumer Health News Source Type: news
